may be required, for example, for nutritional medical issues or for hemodialysis. In this way, a patient's veins are protected from damage caused by frequent punctures or aggressive drugs, which increases

as tumor cells. This type of ILC appears to be less common in NAFLD patients and could be one reason why this group of HCC patients responds less well to the immunotherapies used to date. The research

Deutschland e.V. The aim of the project is to be able to better diagnose and individually treat patients with BA and COPD. Together with the Clinic for Pediatric Pneumology, Allergology and Neonatology

of the University Center for Rare Diseases. "The MHH offers an excellent opportunity to combine patient care and translational research," says Professor Di Donato. Written by Stefan Zorn

inflammatory changes in bronchial asthma and cystic fibrosis. Through studies of mouse models and patient material, we identify mechanisms that influence immunological-inflammatory diseases in the lung in

for Pediatrics and Adolescent Medicine. Since 1983 he has been clinically involved in the care of patients with cystic fibrosis. His scientific work focuses on research in genetics, molecular pathology,

At Hannover Medical School’s ENT Department we carry out numerous projects for our patients’ benefit – some of which are not affordable with our own resources alone. So we can use all the support we can

infections. RESIST includes doctors who work in hospitals and are very familiar with the situation of patients, as well as basic scientists who research pathogens and their interaction with the immune system

work with the highest priority to optimize allogeneic and xenogeneic biomaterials to perfectly meet patients' needs for cell replacement. Our vision to avoid rejection is to create immunologically invisible

mh-hannover.de Read more Prof. Dr. med. Dipl.-Volksw. Frank Lammert Vice President, Board Member for Patient Care +49 511-532-6030 Lammert.Frank @ mh-hannover.de Read more (in German) Dipl. economist Martina